The company is licensing out technology from Australian digital health company TALi Digital to improve attention in early childhood. Akili will pay $37.5 million, including milestone payments and royalties.
Akili Interactive received FDA clearance last year for its game-based digital therapeutic to be used as a treatment for ADHD. Now, the company is testing it to see if it could help people experiencing cognitive dysfunction after Covid-19.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Lightened regulations and cancelled appointments have led to an uptick in the number of patients using digital therapeutics. But companies still face many of the same obstacles as before, including securing coverage and reimbursement from insurers.
As videogames have become mainstream and emerged from the dimly-lit arcade rooms of years past, gaming technology has found increasing application in medical training, pain management, rehab, and digital therapeutics.
Express Scripts will offer payers a curated list of technology and software-enabled applications and devices that have been vetted for safety, effectiveness and usability.
In exchange for ceding rights to develop, sell and market Akili's two lead products in Japan and Taiwan to Shionogi, Akili will receive $20 million upfront and up to $105 million in additional payments dependent on reaching certain development and commercial milestones.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The startup previously developed the Sleepio application, which is targeted at insomnia, and is offered to around 12 million users through partnerships with payers and employers like Boston Medical Center, Comcast and the NHS.
At the CES Digital Health Summit, Daniel Kraft and leaders from Fitbit Health Solutions, Verily and Akili Interactive explored how far we've come and where we're going when it comes to digital health.
"We want this to stand alongside Adderall and other drugs as a doctor-prescribed treatment," CEO Eddie Martucci said. "Our goal is to make this a true digital medicine."